A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation
Prof Aleix Prat MD, Valentina Guarneri MD, Laia Paré PhD, Gaia Griguolo MD, Tomás Pascual MD, Maria V Dieci MD, Núria Chic MD, Blanca González-Farré MD, Antonio Frassoldati MD, Esther Sanfeliu MD, Juan M Cejalvo MD, Montserrat Muñoz MD, Giancarlo Bisagni MD, Fara Brasó-Maristany PhD, Loredana Urso MD, Maria Vidal MD, Alba A Brandes MD, Barbara Adamo MD, Antonino Musolino MD, Federica Miglietta MD, Benedetta Conte MD, Mafalda Oliveira MD, Cristina Saura MD, Sònia Pernas MD, Jesús Alarcón MD, Antonio Llombart-Cussac MD, Javier Cortés MD, Luis Manso MD, Rafael López MD, Eva Ciruelos MD, Francesco Schettini MD, Patricia Villagrasa PhD, Lisa A Carey MD, Charles M Perou PhD, Federico Piacentini MD, Roberto D’Amico MD, Enrico Tagliafico MD, Joel S Parker PhD, Prof Pierfranco Conte MD
Lancet
